Cargando…
An Antibody Fab Fragment-based Chimeric Antigen Receptor Could Efficiently Eliminate Human Thyroid Cancer Cells
Thyroid cancer remains a significant health problem worldwide. Traditional chemotherapy does generate long-term benefit but are usually accompanied by severe side effects. Immunotherapy by adoptive infusion of T cells is now an attractive alternative to chemotherapy. Chimeric antigen receptor engine...
Autores principales: | Duan, Honghong, Huang, Huibin, Jing, Guangjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547977/ https://www.ncbi.nlm.nih.gov/pubmed/31205546 http://dx.doi.org/10.7150/jca.30163 |
Ejemplares similares
-
Development and Characterization of Chimeric Anti‐carcinoembryonic Antigen Monoclonal Antibodies and Their Fab Fragments
por: Kamigaki, Takashi, et al.
Publicado: (1994) -
Distribution of neocarzinostatin conjugated to biotinylated chimeric monoclonal antibody Fab fragments after administration of avidin.
por: Otsuji, E., et al.
Publicado: (1996) -
Production of Antibody Fab Fragments in Escherichia coli
por: Tachibana, Hiroshi, et al.
Publicado: (2011) -
Single chain Fab (scFab) fragment
por: Hust, Michael, et al.
Publicado: (2007) -
Therapy and Imaging of Pancreatic Carcinoma Xenografts with Radioiodine‐labeled Chimeric Monoclonal Antibody A10 and Its Fab Fragment
por: Kamigaki, Takashi, et al.
Publicado: (1995)